Management of known or presumed benign (WHO grade I) meningioma
- John K Park, MD, PhD
John K Park, MD, PhD
- Santa Barbara Neuroscience Institute
- Helen A Shih, MD
Helen A Shih, MD
- Associate Professor of Radiation Oncology
- Harvard Medical School
- Attending Radiation Oncologist
- Massachusetts General Hospital
- Section Editors
- Jay S Loeffler, MD
Jay S Loeffler, MD
- Section Editor — Neurooncology
- Professor of Radiation Oncology
- Harvard Medical School
- Patrick Y Wen, MD
Patrick Y Wen, MD
- Section Editor — Neurooncology
- Professor of Neurology
- Harvard Medical School
Meningiomas account for approximately one-third of primary central nervous system tumors (table 1 and figure 1). Although most meningiomas are benign (World Health Organization [WHO] grade I), their location in the central nervous system can cause serious morbidity and/or mortality. (See "Incidence of primary brain tumors".)
The management of patients with meningioma requires a balance between definitive treatment of the tumor and avoidance of neurologic damage from the treatment. Patient-specific factors (presence or absence of symptoms, age, comorbidity), the location of the meningioma in relation to critical brain structures and regions, and the histopathologic characteristics (WHO grade) of the meningioma all are important factors in determining the optimal treatment.
Depending upon these characteristics, initial management for patients with a benign (WHO grade I) meningioma may consist of surgery, surgery plus radiation therapy, or radiation therapy alone. In addition, for some patients with small, asymptomatic or minimally symptomatic lesions patients may simply be monitored for evidence of tumor growth, with initial treatment deferred.
The initial management of benign (WHO grade I) meningiomas will be reviewed here. Related topics regarding the management of meningioma include:
- Go RS, Taylor BV, Kimmel DW. The natural history of asymptomatic meningiomas in Olmsted County, Minnesota. Neurology 1998; 51:1718.
- Nakamura M, Roser F, Michel J, et al. The natural history of incidental meningiomas. Neurosurgery 2003; 53:62.
- Yano S, Kuratsu J, Kumamoto Brain Tumor Research Group. Indications for surgery in patients with asymptomatic meningiomas based on an extensive experience. J Neurosurg 2006; 105:538.
- Herscovici Z, Rappaport Z, Sulkes J, et al. Natural history of conservatively treated meningiomas. Neurology 2004; 63:1133.
- Gardner PA, Kassam AB, Thomas A, et al. Endoscopic endonasal resection of anterior cranial base meningiomas. Neurosurgery 2008; 63:36.
- Nanda A, Bir SC, Maiti TK, et al. Relevance of Simpson grading system and recurrence-free survival after surgery for World Health Organization Grade I meningioma. J Neurosurg 2016; :1.
- Marciscano AE, Stemmer-Rachamimov AO, Niemierko A, et al. Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes. J Neurosurg 2016; 124:106.
- Kotecha RS, Pascoe EM, Rushing EJ, et al. Meningiomas in children and adolescents: a meta-analysis of individual patient data. Lancet Oncol 2011; 12:1229.
- Oya S, Kawai K, Nakatomi H, Saito N. Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas. J Neurosurg 2012; 117:121.
- SIMPSON D. The recurrence of intracranial meningiomas after surgical treatment. J Neurol Neurosurg Psychiatry 1957; 20:22.
- Stafford SL, Perry A, Suman VJ, et al. Primarily resected meningiomas: outcome and prognostic factors in 581 Mayo Clinic patients, 1978 through 1988. Mayo Clin Proc 1998; 73:936.
- Kallio M, Sankila R, Hakulinen T, Jääskeläinen J. Factors affecting operative and excess long-term mortality in 935 patients with intracranial meningioma. Neurosurgery 1992; 31:2.
- Oka H, Kurata A, Kawano N, et al. Preoperative superselective embolization of skull-base meningiomas: indications and limitations. J Neurooncol 1998; 40:67.
- Rosen CL, Ammerman JM, Sekhar LN, Bank WO. Outcome analysis of preoperative embolization in cranial base surgery. Acta Neurochir (Wien) 2002; 144:1157.
- Carli DF, Sluzewski M, Beute GN, van Rooij WJ. Complications of particle embolization of meningiomas: frequency, risk factors, and outcome. AJNR Am J Neuroradiol 2010; 31:152.
- Dowd CF, Halbach VV, Higashida RT. Meningiomas: the role of preoperative angiography and embolization. Neurosurg Focus 2003; 15:E10.
- Shah AH, Patel N, Raper DM, et al. The role of preoperative embolization for intracranial meningiomas. J Neurosurg 2013; 119:364.
- Awad IA, Kalfas I, Hahn JF, Little JR. Intracranial meningiomas in the aged: surgical outcome in the era of computed tomography. Neurosurgery 1989; 24:557.
- Black P, Kathiresan S, Chung W. Meningioma surgery in the elderly: a case-control study assessing morbidity and mortality. Acta Neurochir (Wien) 1998; 140:1013.
- Sacko O, Sesay M, Roux FE, et al. Intracranial meningioma surgery in the ninth decade of life. Neurosurgery 2007; 61:950.
- Sawaya R, Zuccarello M, Elkalliny M, Nishiyama H. Postoperative venous thromboembolism and brain tumors: Part I. Clinical profile. J Neurooncol 1992; 14:119.
- Sawaya R, Glas-Greenwalt P. Postoperative venous thromboembolism and brain tumors: Part II. Hemostatic profile. J Neurooncol 1992; 14:127.
- Rogers L, Barani I, Chamberlain M, et al. Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review. J Neurosurg 2015; 122:4.
- Glaholm J, Bloom HJ, Crow JH. The role of radiotherapy in the management of intracranial meningiomas: the Royal Marsden Hospital experience with 186 patients. Int J Radiat Oncol Biol Phys 1990; 18:755.
- Forbes AR, Goldberg ID. Radiation therapy in the treatment of meningioma: the Joint Center for Radiation Therapy experience 1970 to 1982. J Clin Oncol 1984; 2:1139.
- Taylor BW Jr, Marcus RB Jr, Friedman WA, et al. The meningioma controversy: postoperative radiation therapy. Int J Radiat Oncol Biol Phys 1988; 15:299.
- Goldsmith BJ, Wara WM, Wilson CB, Larson DA. Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. J Neurosurg 1994; 80:195.
- Korah MP, Nowlan AW, Johnstone PA, Crocker IR. Radiation therapy alone for imaging-defined meningiomas. Int J Radiat Oncol Biol Phys 2010; 76:181.
- Lee JY, Niranjan A, McInerney J, et al. Stereotactic radiosurgery providing long-term tumor control of cavernous sinus meningiomas. J Neurosurg 2002; 97:65.
- Hakim R, Alexander E 3rd, Loeffler JS, et al. Results of linear accelerator-based radiosurgery for intracranial meningiomas. Neurosurgery 1998; 42:446.
- Nicolato A, Foroni R, Alessandrini F, et al. Radiosurgical treatment of cavernous sinus meningiomas: experience with 122 treated patients. Neurosurgery 2002; 51:1153.
- Kondziolka D, Flickinger JC, Perez B. Judicious resection and/or radiosurgery for parasagittal meningiomas: outcomes from a multicenter review. Gamma Knife Meningioma Study Group. Neurosurgery 1998; 43:405.
- Pollock BE, Stafford SL, Link MJ, et al. Single-fraction radiosurgery for presumed intracranial meningiomas: efficacy and complications from a 22-year experience. Int J Radiat Oncol Biol Phys 2012; 83:1414.
- Spiegelmann R, Cohen ZR, Nissim O, et al. Cavernous sinus meningiomas: a large LINAC radiosurgery series. J Neurooncol 2010; 98:195.
- Skeie BS, Enger PO, Skeie GO, et al. Gamma knife surgery of meningiomas involving the cavernous sinus: long-term follow-up of 100 patients. Neurosurgery 2010; 66:661.
- Debus J, Wuendrich M, Pirzkall A, et al. High efficacy of fractionated stereotactic radiotherapy of large base-of-skull meningiomas: long-term results. J Clin Oncol 2001; 19:3547.
- Milker-Zabel S, Zabel A, Schulz-Ertner D, et al. Fractionated stereotactic radiotherapy in patients with benign or atypical intracranial meningioma: long-term experience and prognostic factors. Int J Radiat Oncol Biol Phys 2005; 61:809.
- Arvold ND, Lessell S, Bussiere M, et al. Visual outcome and tumor control after conformal radiotherapy for patients with optic nerve sheath meningioma. Int J Radiat Oncol Biol Phys 2009; 75:1166.
- Minniti G, Amichetti M, Enrici RM. Radiotherapy and radiosurgery for benign skull base meningiomas. Radiat Oncol 2009; 4:42.
- Milker-Zabel S, Zabel-du Bois A, Huber P, et al. Intensity-modulated radiotherapy for complex-shaped meningioma of the skull base: long-term experience of a single institution. Int J Radiat Oncol Biol Phys 2007; 68:858.
- Combs SE, Hartmann C, Nikoghosyan A, et al. Carbon ion radiation therapy for high-risk meningiomas. Radiother Oncol 2010; 95:54.
- Halasz LM, Bussière MR, Dennis ER, et al. Proton stereotactic radiosurgery for the treatment of benign meningiomas. Int J Radiat Oncol Biol Phys 2011; 81:1428.
- Fokas E, Henzel M, Surber G, et al. Stereotactic radiotherapy of benign meningioma in the elderly: clinical outcome and toxicity in 121 patients. Radiother Oncol 2014; 111:457.
- Laigle-Donadey F, Taillibert S, Mokhtari K, et al. Dural metastases. J Neurooncol 2005; 75:57.
- Morokoff AP, Zauberman J, Black PM. Surgery for convexity meningiomas. Neurosurgery 2008; 63:427.
- Black PM, Villavicencio AT, Rhouddou C, Loeffler JS. Aggressive surgery and focal radiation in the management of meningiomas of the skull base: preservation of function with maintenance of local control. Acta Neurochir (Wien) 2001; 143:555.
- Mendenhall WM, Morris CG, Amdur RJ, et al. Radiotherapy alone or after subtotal resection for benign skull base meningiomas. Cancer 2003; 98:1473.
- Saeed P, Blank L, Selva D, et al. Primary radiotherapy in progressive optic nerve sheath meningiomas: a long-term follow-up study. Br J Ophthalmol 2010; 94:564.
- Lesser RL, Knisely JP, Wang SL, et al. Long-term response to fractionated radiotherapy of presumed optic nerve sheath meningioma. Br J Ophthalmol 2010; 94:559.
- Milker-Zabel S, Huber P, Schlegel W, et al. Fractionated stereotactic radiation therapy in the management of primary optic nerve sheath meningiomas. J Neurooncol 2009; 94:419.
- Galloway TJ, Indelicato DJ, Amdur RJ, et al. Favorable outcomes of pediatric patients treated with radiotherapy to the central nervous system who develop radiation-induced meningiomas. Int J Radiat Oncol Biol Phys 2011; 79:117.
- Kondziolka D, Kano H, Kanaan H, et al. Stereotactic radiosurgery for radiation-induced meningiomas. Neurosurgery 2009; 64:463.
- Kalkanis SN, Quiñones-Hinojosa A, Buzney E, et al. Quality of life following surgery for intracranial meningiomas at Brigham and Women's Hospital: a study of 164 patients using a modification of the functional assessment of cancer therapy-brain questionnaire. J Neurooncol 2000; 48:233.
- Dijkstra M, van Nieuwenhuizen D, Stalpers LJ, et al. Late neurocognitive sequelae in patients with WHO grade I meningioma. J Neurol Neurosurg Psychiatry 2009; 80:910.
- Chuang HC, Lee HC, Cho DY. Intracranial malignant meningioma with multiple spinal metastases--a case report and literature review: case report. Spine (Phila Pa 1976) 2006; 31:E1006.
- Chamberlain MC, Glantz MJ. Cerebrospinal fluid-disseminated meningioma. Cancer 2005; 103:1427.
- Slavin ML. Metastatic malignant meningioma. J Clin Neuroophthalmol 1989; 9:55.
- Figueroa BE, Quint DJ, McKeever PE, Chandler WF. Extracranial metastatic meningioma. Br J Radiol 1999; 72:513.
- APPROACH TO INITIAL THERAPY
- Presumptive diagnosis of meningioma
- Small, asymptomatic tumors
- Large or symptomatic tumors
- - Extent of resection
- - Surgical morbidity
- - Perioperative medical management
- Cerebral edema
- Deep venous thrombosis
- - RT after partial resection
- Nonresectable tumors
- - Radiation techniques
- Stereotactic radiosurgery
- Stereotactic radiotherapy
- Intensity-modulated RT
- Volumetric-modulated arc RT
- Particle therapy
- Older adults
- Patients with a history of cancer
- ONCOLOGIC AND FUNCTIONAL OUTCOMES
- Convexity meningiomas
- Skull base meningiomas
- Optic nerve sheath meningiomas
- Radiation-induced meningiomas
- Quality of life
- SURVEILLANCE AFTER INITIAL TREATMENT
- RECURRENT DISEASE
- INFORMATION FOR PATIENTS
- SUMMARY AND RECOMMENDATIONS